Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 4, 2015
- Accepted in final form June 3, 2015
- First Published September 9, 2015.
Article Versions
- Previous version (September 9, 2015 - 13:00).
- Previous version (September 30, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Sebastian Palmqvist, MD, PhD,
- Henrik Zetterberg, MD, PhD,
- Niklas Mattsson, MD, PhD,
- Per Johansson, MD, PhD;
- For the Alzheimer's Disease Neuroimaging Initiative,
- Lennart Minthon, MD, PhD,
- Kaj Blennow, MD, PhD,
- Mattias Olsson, PhD;
- For the Swedish BioFINDER study group and
- Oskar Hansson, MD, PhD
- Sebastian Palmqvist, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Henrik Zetterberg, MD, PhD,
NONE
NONE
NONE
Journal of Alzheimer's Disease, Senior Editor Alzheimer's & Dementia, Associate Editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) The Swedish Research Council (K2010-63P-21562-01-4, K2011-61X-20401-05-6); (2) Swedish State Support for Clinical Research (ALFGBG-144341)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Niklas Mattsson, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swedish Research Council, Sahlgrenska University Hospital, Sahlgrenska Academy, Goteborgs Lakaresallskap, Svenska Lakareskallskapet, Klinisk Biokemi i Norden, Carl-Bertil Laurells foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- Per Johansson, MD, PhD;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- For the Alzheimer's Disease Neuroimaging Initiative,
- Lennart Minthon, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kaj Blennow, MD, PhD,
Dr Blennow has served at advisory boards for Eli Lilly, IBL International, Roche Diagnostics.
NONE
Fujirebio Europe
NONE
NONE
NONE
NONE
Novartis
NONE
NONE
NONE
NONE
The Research Council, Sweden (project # 14002), and LUA/ALF project, V?stra G?talandsregionen, Sweden (project # ALFGBG-11019)
NONE
The Torsten S?derberg Foundation at the royal Swedish Academy of Sciences, the Stiftelsen f?r Gamla Tj?narinnor, and Hj?rnfonden, Sweden.
NONE
NONE
NONE
NONE
NONE
NONE
- Mattias Olsson, PhD;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- For the Swedish BioFINDER study group and
- Oskar Hansson, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The support is listed in the manuscript.
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Palmqvist: sebastian.palmqvist{at}med.lu.se or Dr. Hansson: oskar.hansson{at}med.lu.se
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan